Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): a double-blind placebo-controlled randomized trial
Bejan-Angoulvant, Theodora, Naccache, Jean-Marc, Caille, Agnès, Borie, Raphael, Nunes, Hilario, Ferreira, Marion, Cadranel, Jacques, Crestani, Bruno, Cottin, Vincent, Marchand-Adam, SylvainJournal:
Respiratory Medicine and Research
DOI:
10.1016/j.resmer.2020.100770
Date:
May, 2020
File:
PDF, 594 KB
2020
File converter
More search results
More benefits 
